Skip to main content
Top
Published in: Endocrine 2/2018

01-02-2018 | Original Article

The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women

Authors: Dong-mei Liu, Hong-yan Zhao, Lin Zhao, Min-jia Zhang, Ting-ting Liu, Bei Tao, Li-hao Sun, Jian-min Liu

Published in: Endocrine | Issue 2/2018

Login to get access

Abstract

Purpose

We aimed to investigate associations among serum levels of LCN2, bone resorption marker carboxy-terminal cross-linking telopeptide of type-1 collagen (CTx), bone formation marker osteocalcin (OCN), and bone mineral densities (BMDs) in ambulatory healthy women.

Methods

This cross-sectional study analyzed 1012 previously enrolled outpatient Han Chinese women. BMDs of the lumbar spine and femoral neck were measured using dual energy X-ray absorptiometry. Serum levels of LCN2, CTx, OCN, and creatinine (Scr) were measured.

Results

Circulating LCN2 was inversely correlated with BMDs at the lumbar spine and femoral neck (Spearman’s r = −0.08, P = 0.010 and r = −0.14, P < 0.001; respectively). A significant positive correlation between LCN2 and CTx (r = 0.11, P < 0.001), OCN (r = 0.06, P = 0.047), age (r = 0.21, P < 0.001), and Scr (r = 0.24, P < 0.001) was also observed. After adjusting for age and Scr, the correlation among LCN2, BMDs and OCN disappeared, but LCN2 was still positively associated with CTx (r = 0.08, P = 0.010). The circulating concentration of LCN2 showed no significant difference between subjects with and without osteoporotic fractures (43.63 (35.29, 53.66) vs. 42.25 (34.43, 51.46) ng/ml, respectively, P = 0.111). Serum CTx concentrations rose with serum LCN2 increasing from the lowest to the highest quartile (P for trend = 0.005), even after adjusting for age and Scr (P for trend = 0.040). In multivariate regression analysis, LCN2 was one of the main determinants for changes in serum CTx (standard β = 0.061, P = 0.005).

Conclusions

In ambulatory healthy women, the relationships among serum LCN2 level, BMDs, and OCN were confounded by age and Scr. Although LCN2 was positively related with CTx, the correlation was very weak and may not be physiologically relevant.
Literature
3.
go back to reference W. Wei, T. Motoike, J.Y. Krzeszinski, Z. Jin, X.J. Xie, P.C. Dechow, M. Yanagisawa, Y. Wan, Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action. Cell. Metab. 19, 927–940 (2014)CrossRefPubMedPubMedCentral W. Wei, T. Motoike, J.Y. Krzeszinski, Z. Jin, X.J. Xie, P.C. Dechow, M. Yanagisawa, Y. Wan, Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action. Cell. Metab. 19, 927–940 (2014)CrossRefPubMedPubMedCentral
4.
go back to reference S.K. Ramasamy, A.P. Kusumbe, L. Wang, R.H. Adams, Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014)CrossRefPubMedPubMedCentral S.K. Ramasamy, A.P. Kusumbe, L. Wang, R.H. Adams, Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014)CrossRefPubMedPubMedCentral
5.
go back to reference K. Ikeda, S. Takeshita, Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts. J. Bone Metab. 21, 163–167 (2014)CrossRefPubMedPubMedCentral K. Ikeda, S. Takeshita, Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts. J. Bone Metab. 21, 163–167 (2014)CrossRefPubMedPubMedCentral
6.
go back to reference S. Hraba-Renevey, H. Turler, M. Kress, C. Salomon, R. Weil, SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4, 601–608 (1989)PubMed S. Hraba-Renevey, H. Turler, M. Kress, C. Salomon, R. Weil, SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4, 601–608 (1989)PubMed
7.
go back to reference L. Kjeldsen, A.H. Johnsen, H. Sengelov, N. Borregaard, Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268, 10425–10432 (1993)PubMed L. Kjeldsen, A.H. Johnsen, H. Sengelov, N. Borregaard, Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268, 10425–10432 (1993)PubMed
8.
go back to reference T.H. Flo, K.D. Smith, S. Sato, D.J. Rodriguez, M.A. Holmes, R.K. Strong, S. Akira, A. Aderem, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921 (2004)CrossRefPubMed T.H. Flo, K.D. Smith, S. Sato, D.J. Rodriguez, M.A. Holmes, R.K. Strong, S. Akira, A. Aderem, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921 (2004)CrossRefPubMed
9.
go back to reference Q.W. Yan, Q. Yang, N. Mody, T.E. Graham, C.H. Hsu, Z. Xu, N.E. Houstis, B.B. Kahn, E.D. Rosen, The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56, 2533–2540 (2007)CrossRefPubMed Q.W. Yan, Q. Yang, N. Mody, T.E. Graham, C.H. Hsu, Z. Xu, N.E. Houstis, B.B. Kahn, E.D. Rosen, The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56, 2533–2540 (2007)CrossRefPubMed
10.
go back to reference I. Mosialou, S. Shikhel, J.M. Liu, A. Maurizi, N. Luo, Z. He, Y. Huang, H. Zong, R.A. Friedman, J. Barasch, P. Lanzano, L. Deng, R.L. Leibel, M. Rubin, T. Nicholas, W. Chung, L.M. Zeltser, K.W. Williams, J.E. Pessin, S. Kousteni, MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543, 385–390 (2017)CrossRefPubMed I. Mosialou, S. Shikhel, J.M. Liu, A. Maurizi, N. Luo, Z. He, Y. Huang, H. Zong, R.A. Friedman, J. Barasch, P. Lanzano, L. Deng, R.L. Leibel, M. Rubin, T. Nicholas, W. Chung, L.M. Zeltser, K.W. Williams, J.E. Pessin, S. Kousteni, MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543, 385–390 (2017)CrossRefPubMed
11.
go back to reference Y. Wang, K.S. Lam, E.W. Kraegen, G. Sweeney, J. Zhang, A.W. Tso, W.S. Chow, N.M. Wat, J.Y. Xu, R.L. Hoo, A. Xu, Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 53, 34–41 (2007)CrossRefPubMed Y. Wang, K.S. Lam, E.W. Kraegen, G. Sweeney, J. Zhang, A.W. Tso, W.S. Chow, N.M. Wat, J.Y. Xu, R.L. Hoo, A. Xu, Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 53, 34–41 (2007)CrossRefPubMed
12.
go back to reference A. Viau, K. El Karoui, D. Laouari, M. Burtin, C. Nguyen, K. Mori, E. Pillebout, T. Berger, T.W. Mak, B. Knebelmann, G. Friedlander, J. Barasch, F. Terzi, Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 120, 4065–4076 (2010)CrossRefPubMedPubMedCentral A. Viau, K. El Karoui, D. Laouari, M. Burtin, C. Nguyen, K. Mori, E. Pillebout, T. Berger, T.W. Mak, B. Knebelmann, G. Friedlander, J. Barasch, F. Terzi, Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 120, 4065–4076 (2010)CrossRefPubMedPubMedCentral
13.
go back to reference X. Leng, T. Ding, H. Lin, Y. Wang, L. Hu, J. Hu, B. Feig, W. Zhang, L. Pusztai, W.F. Symmans, Y. Wu, R.B. Arlinghaus, Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 69, 8579–8584 (2009)CrossRefPubMed X. Leng, T. Ding, H. Lin, Y. Wang, L. Hu, J. Hu, B. Feig, W. Zhang, L. Pusztai, W.F. Symmans, Y. Wu, R.B. Arlinghaus, Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 69, 8579–8584 (2009)CrossRefPubMed
14.
go back to reference M. Mucha, A. Skrzypiec, E. Schiavon, B. Attwood, E. Kucerova, R. Pawlak, Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. USA 108, 18436–18441 (2011)CrossRefPubMedPubMedCentral M. Mucha, A. Skrzypiec, E. Schiavon, B. Attwood, E. Kucerova, R. Pawlak, Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. USA 108, 18436–18441 (2011)CrossRefPubMedPubMedCentral
15.
go back to reference S. Lindberg, S.H. Pedersen, R. Mogelvang, J.S. Jensen, A. Flyvbjerg, S. Galatius, N.E. Magnusson, Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J. Am. Coll. Cardiol. 60, 339–345 (2012)CrossRefPubMed S. Lindberg, S.H. Pedersen, R. Mogelvang, J.S. Jensen, A. Flyvbjerg, S. Galatius, N.E. Magnusson, Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J. Am. Coll. Cardiol. 60, 339–345 (2012)CrossRefPubMed
16.
go back to reference J.M. Warszawska, R. Gawish, O. Sharif, S. Sigel, B. Doninger, K. Lakovits, I. Mesteri, M. Nairz, L. Boon, A. Spiel, V. Fuhrmann, B. Strobl, M. Muller, P. Schenk, G. Weiss, S. Knapp, Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Invest. 123, 3363–3372 (2013)CrossRefPubMedPubMedCentral J.M. Warszawska, R. Gawish, O. Sharif, S. Sigel, B. Doninger, K. Lakovits, I. Mesteri, M. Nairz, L. Boon, A. Spiel, V. Fuhrmann, B. Strobl, M. Muller, P. Schenk, G. Weiss, S. Knapp, Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Invest. 123, 3363–3372 (2013)CrossRefPubMedPubMedCentral
17.
go back to reference M. Capulli, A. Rufo, A. Teti, N. Rucci, Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a “mechanoresponsive osteoblast gene signature”. J. Cell. Biochem. 107, 240–252 (2009)CrossRefPubMed M. Capulli, A. Rufo, A. Teti, N. Rucci, Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a “mechanoresponsive osteoblast gene signature”. J. Cell. Biochem. 107, 240–252 (2009)CrossRefPubMed
18.
go back to reference N. Rucci, M. Capulli, S.G. Piperni, A. Cappariello, P. Lau, P. Frings-Meuthen, M. Heer, A. Teti, Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J. Bone Miner. Res. 30, 357–368 (2015)CrossRefPubMed N. Rucci, M. Capulli, S.G. Piperni, A. Cappariello, P. Lau, P. Frings-Meuthen, M. Heer, A. Teti, Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J. Bone Miner. Res. 30, 357–368 (2015)CrossRefPubMed
19.
go back to reference V. Veeriah, A. Zanniti, R. Paone, S. Chatterjee, N. Rucci, A. Teti, M. Capulli, Interleukin-1beta, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk. Sci. Rep. 6, 29880 (2016)CrossRefPubMedPubMedCentral V. Veeriah, A. Zanniti, R. Paone, S. Chatterjee, N. Rucci, A. Teti, M. Capulli, Interleukin-1beta, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk. Sci. Rep. 6, 29880 (2016)CrossRefPubMedPubMedCentral
20.
go back to reference M. Lu, L. Xia, Y.C. Liu, T. Hochman, L. Bizzari, D. Aruch, J. Lew, R. Weinberg, J.D. Goldberg, R. Hoffman, Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells. Blood 126, 972–982 (2015)CrossRefPubMedPubMedCentral M. Lu, L. Xia, Y.C. Liu, T. Hochman, L. Bizzari, D. Aruch, J. Lew, R. Weinberg, J.D. Goldberg, R. Hoffman, Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells. Blood 126, 972–982 (2015)CrossRefPubMedPubMedCentral
21.
go back to reference H.J. Kim, H.J. Yoon, K.A. Yoon, M.R. Gwon, S. Jin Seong, K. Suk, S.Y. Kim, Y.R. Yoon, Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells. Exp. Cell. Res. 334, 301–309 (2015)CrossRefPubMed H.J. Kim, H.J. Yoon, K.A. Yoon, M.R. Gwon, S. Jin Seong, K. Suk, S.Y. Kim, Y.R. Yoon, Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells. Exp. Cell. Res. 334, 301–309 (2015)CrossRefPubMed
22.
go back to reference H.J. Kim, B. Ohk, W.Y. Kang, S.J. Seong, K. Suk, M.S. Lim, S.Y. Kim, Y.R. Yoon, Deficiency of lipocalin-2 promotes proliferation and differentiation of osteoclast precursors via regulation of c-Fms expression and nuclear factor-kappa B activation. J. Bone Metab. 23, 8–15 (2016)CrossRefPubMedPubMedCentral H.J. Kim, B. Ohk, W.Y. Kang, S.J. Seong, K. Suk, M.S. Lim, S.Y. Kim, Y.R. Yoon, Deficiency of lipocalin-2 promotes proliferation and differentiation of osteoclast precursors via regulation of c-Fms expression and nuclear factor-kappa B activation. J. Bone Metab. 23, 8–15 (2016)CrossRefPubMedPubMedCentral
23.
go back to reference P. Frings-Meuthen, J. Buehlmeier, N. Baecker, P. Stehle, R. Fimmers, F. May, G. Kluge, M. Heer, High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J. Appl. Physiol. 111, 537–542 (2011)CrossRefPubMed P. Frings-Meuthen, J. Buehlmeier, N. Baecker, P. Stehle, R. Fimmers, F. May, G. Kluge, M. Heer, High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J. Appl. Physiol. 111, 537–542 (2011)CrossRefPubMed
24.
go back to reference W.H. Lim, G. Wong, E.M. Lim, E. Byrnes, K. Zhu, A. Devine, N.J. Pavlos, R.L. Prince, J.R. Lewis, Circulating lipocalin 2 levels predict fracture-related hospitalizations in elderly women: a prospective cohort study. J. Bone Miner. Res. 30, 2078–2085 (2015)CrossRefPubMed W.H. Lim, G. Wong, E.M. Lim, E. Byrnes, K. Zhu, A. Devine, N.J. Pavlos, R.L. Prince, J.R. Lewis, Circulating lipocalin 2 levels predict fracture-related hospitalizations in elderly women: a prospective cohort study. J. Bone Miner. Res. 30, 2078–2085 (2015)CrossRefPubMed
25.
go back to reference C. Cervellati, G. Bonaccorsi, C. Bergamini, E. Fila, P. Greco, G. Valacchi, L. Massari, A. Gonelli, V. Tisato, Association between circulatory levels of adipokines and bone mineral density in postmenopausal women. Menopause 23, 984–992 (2016)CrossRefPubMed C. Cervellati, G. Bonaccorsi, C. Bergamini, E. Fila, P. Greco, G. Valacchi, L. Massari, A. Gonelli, V. Tisato, Association between circulatory levels of adipokines and bone mineral density in postmenopausal women. Menopause 23, 984–992 (2016)CrossRefPubMed
26.
go back to reference C.M. Paton, M.P. Rogowski, A.L. Kozimor, J.L. Stevenson, H. Chang, J.A. Cooper, Lipocalin-2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women. Obesity 21, E640–E648 (2013)CrossRefPubMed C.M. Paton, M.P. Rogowski, A.L. Kozimor, J.L. Stevenson, H. Chang, J.A. Cooper, Lipocalin-2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women. Obesity 21, E640–E648 (2013)CrossRefPubMed
27.
go back to reference N.M. Rashad, A.S. El-Shal, R.L. Etewa, F.M. Wadea, Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women. IUBMB Life 69, 88–97 (2017)CrossRefPubMed N.M. Rashad, A.S. El-Shal, R.L. Etewa, F.M. Wadea, Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women. IUBMB Life 69, 88–97 (2017)CrossRefPubMed
28.
go back to reference T. Auguet, Y. Quintero, X. Terra, S. Martinez, A. Lucas, S. Pellitero, C. Aguilar, M. Hernandez, D. del Castillo, C. Richart, Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity 19, 2295–2300 (2011)CrossRefPubMed T. Auguet, Y. Quintero, X. Terra, S. Martinez, A. Lucas, S. Pellitero, C. Aguilar, M. Hernandez, D. del Castillo, C. Richart, Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity 19, 2295–2300 (2011)CrossRefPubMed
29.
go back to reference J. Mishra, C. Dent, R. Tarabishi, M.M. Mitsnefes, Q. Ma, C. Kelly, S.M. Ruff, K. Zahedi, M. Shao, J. Bean, K. Mori, J. Barasch, P. Devarajan, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365, 1231–1238 (2005)CrossRefPubMed J. Mishra, C. Dent, R. Tarabishi, M.M. Mitsnefes, Q. Ma, C. Kelly, S.M. Ruff, K. Zahedi, M. Shao, J. Bean, K. Mori, J. Barasch, P. Devarajan, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365, 1231–1238 (2005)CrossRefPubMed
30.
go back to reference M. Haase, R. Bellomo, P. Devarajan, P. Schlattmann, A. Haase-Fielitz, and N.M.-a.I. Group, Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54, 1012–1024 (2009) M. Haase, R. Bellomo, P. Devarajan, P. Schlattmann, A. Haase-Fielitz, and N.M.-a.I. Group, Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54, 1012–1024 (2009)
31.
go back to reference J. Wang, H. Zhu, J. Xue, S. Wu, Z. Chen, Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2. Int. J. Clin. Exp. Pathol. 8, 4099–4105 (2015)PubMedPubMedCentral J. Wang, H. Zhu, J. Xue, S. Wu, Z. Chen, Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2. Int. J. Clin. Exp. Pathol. 8, 4099–4105 (2015)PubMedPubMedCentral
32.
go back to reference D. Sulistyoningrum, D. Gasevic, S. Lear, J. Ho, A. Mente, A. Devlin, Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc. Diabetol. 12, 170 (2013)CrossRefPubMedPubMedCentral D. Sulistyoningrum, D. Gasevic, S. Lear, J. Ho, A. Mente, A. Devlin, Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc. Diabetol. 12, 170 (2013)CrossRefPubMedPubMedCentral
33.
Metadata
Title
The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women
Authors
Dong-mei Liu
Hong-yan Zhao
Lin Zhao
Min-jia Zhang
Ting-ting Liu
Bei Tao
Li-hao Sun
Jian-min Liu
Publication date
01-02-2018
Publisher
Springer US
Published in
Endocrine / Issue 2/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1504-1

Other articles of this Issue 2/2018

Endocrine 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.